Fortis Malar Hospitals Ltd
BSE:523696
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fortis Malar Hospitals Ltd
BSE:523696
|
IN |
Balance Sheet
Balance Sheet Decomposition
Fortis Malar Hospitals Ltd
Fortis Malar Hospitals Ltd
Balance Sheet
Fortis Malar Hospitals Ltd
| Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Cash & Cash Equivalents |
1
|
15
|
3
|
3
|
7
|
30
|
102
|
186
|
253
|
76
|
147
|
66
|
431
|
74
|
124
|
59
|
2
|
|
| Cash |
1
|
15
|
3
|
3
|
7
|
30
|
102
|
28
|
220
|
4
|
2
|
0
|
0
|
0
|
0
|
8
|
2
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
158
|
33
|
72
|
145
|
66
|
430
|
74
|
124
|
51
|
0
|
|
| Short-Term Investments |
0
|
0
|
7
|
0
|
0
|
0
|
0
|
46
|
53
|
106
|
68
|
157
|
23
|
84
|
9
|
49
|
316
|
|
| Total Receivables |
78
|
80
|
131
|
149
|
728
|
666
|
666
|
655
|
673
|
751
|
886
|
867
|
131
|
411
|
325
|
718
|
5
|
|
| Accounts Receivables |
15
|
30
|
75
|
61
|
36
|
32
|
39
|
42
|
60
|
56
|
60
|
97
|
41
|
32
|
38
|
36
|
5
|
|
| Other Receivables |
63
|
50
|
56
|
88
|
692
|
634
|
627
|
613
|
613
|
696
|
826
|
771
|
90
|
379
|
287
|
681
|
0
|
|
| Inventory |
0
|
5
|
6
|
4
|
5
|
4
|
3
|
10
|
26
|
23
|
20
|
16
|
17
|
19
|
21
|
14
|
0
|
|
| Other Current Assets |
4
|
3
|
4
|
5
|
10
|
27
|
49
|
13
|
18
|
12
|
11
|
14
|
19
|
12
|
12
|
5
|
19
|
|
| Total Current Assets |
82
|
104
|
150
|
161
|
750
|
727
|
820
|
910
|
1 023
|
969
|
1 132
|
1 121
|
620
|
600
|
491
|
845
|
341
|
|
| PP&E Net |
159
|
230
|
310
|
353
|
395
|
173
|
174
|
176
|
214
|
220
|
221
|
206
|
784
|
675
|
570
|
472
|
0
|
|
| PP&E Gross |
159
|
230
|
310
|
353
|
395
|
173
|
0
|
0
|
0
|
0
|
0
|
0
|
784
|
675
|
570
|
472
|
0
|
|
| Accumulated Depreciation |
172
|
190
|
215
|
184
|
174
|
80
|
0
|
0
|
0
|
0
|
0
|
0
|
161
|
193
|
226
|
260
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
1
|
1
|
8
|
8
|
35
|
32
|
24
|
20
|
28
|
14
|
7
|
2
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
32
|
1
|
13
|
17
|
0
|
72
|
97
|
140
|
451
|
318
|
452
|
61
|
27
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
|
| Other Long-Term Assets |
154
|
166
|
114
|
34
|
6
|
7
|
0
|
3
|
4
|
14
|
17
|
22
|
52
|
85
|
85
|
0
|
0
|
|
| Total Assets |
395
N/A
|
500
+26%
|
573
+15%
|
547
-5%
|
1 184
+116%
|
908
-23%
|
1 015
+12%
|
1 114
+10%
|
1 302
+17%
|
1 307
+0%
|
1 491
+14%
|
1 509
+1%
|
1 935
+28%
|
1 691
-13%
|
1 609
-5%
|
1 380
-14%
|
368
-73%
|
|
| Liabilities | ||||||||||||||||||
| Accounts Payable |
29
|
47
|
61
|
88
|
63
|
78
|
103
|
132
|
211
|
141
|
251
|
235
|
189
|
144
|
200
|
203
|
43
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
5
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
17
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
50
|
38
|
70
|
82
|
0
|
|
| Other Current Liabilities |
36
|
45
|
39
|
59
|
676
|
39
|
56
|
49
|
111
|
163
|
195
|
203
|
117
|
65
|
44
|
13
|
23
|
|
| Total Current Liabilities |
65
|
92
|
100
|
147
|
776
|
131
|
160
|
188
|
322
|
305
|
446
|
439
|
356
|
247
|
314
|
318
|
66
|
|
| Long-Term Debt |
23
|
100
|
165
|
91
|
46
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
594
|
534
|
464
|
382
|
0
|
|
| Deferred Income Tax |
28
|
28
|
29
|
30
|
24
|
6
|
7
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
7
|
14
|
16
|
22
|
23
|
30
|
39
|
0
|
|
| Total Liabilities |
116
N/A
|
220
+90%
|
294
+33%
|
268
-9%
|
847
+216%
|
137
-84%
|
167
+22%
|
190
+14%
|
326
+71%
|
311
-4%
|
460
+48%
|
455
-1%
|
971
+114%
|
804
-17%
|
808
+1%
|
738
-9%
|
66
-91%
|
|
| Equity | ||||||||||||||||||
| Common Stock |
186
|
186
|
186
|
186
|
186
|
186
|
186
|
186
|
186
|
187
|
187
|
188
|
188
|
188
|
188
|
188
|
188
|
|
| Retained Earnings |
93
|
93
|
93
|
93
|
57
|
492
|
662
|
737
|
790
|
809
|
843
|
866
|
681
|
603
|
521
|
358
|
19
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
93
|
93
|
0
|
0
|
0
|
0
|
0
|
0
|
96
|
96
|
96
|
96
|
96
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
0
|
0
|
|
| Total Equity |
279
N/A
|
279
N/A
|
279
N/A
|
279
N/A
|
336
+20%
|
771
+129%
|
848
+10%
|
923
+9%
|
976
+6%
|
995
+2%
|
1 030
+4%
|
1 054
+2%
|
964
-9%
|
887
-8%
|
801
-10%
|
642
-20%
|
302
-53%
|
|
| Total Liabilities & Equity |
395
N/A
|
500
+26%
|
573
+15%
|
547
-5%
|
1 184
+116%
|
908
-23%
|
1 015
+12%
|
1 114
+10%
|
1 302
+17%
|
1 307
+0%
|
1 491
+14%
|
1 509
+1%
|
1 935
+28%
|
1 691
-13%
|
1 609
-5%
|
1 380
-14%
|
368
-73%
|
|
| Shares Outstanding | ||||||||||||||||||
| Common Shares Outstanding |
19
|
19
|
19
|
19
|
19
|
19
|
19
|
19
|
19
|
19
|
19
|
19
|
19
|
19
|
19
|
19
|
19
|
|